accountAVAFIN: Abbott Laboratories - Market Review
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ABBOTT LABORATORIES
Abbott Laboratories is a diversified pharmaceuticals healthcare company headquartered in Abbot Part, Illinois. It operates in four segments: pharmaceutical products; diagnostic products; nutritional products; and vascular products. In 1985, Abbott develop dthe first HIV screen test. The company’s drug portfolio includes Humira, Synthroid, and Dupakote; and its most popular nutritional product is Ensure.
Abbott Laboratories is part of Business Exchange, suggested by
Maki Yamasaki.
This topic contains
921 news
and
191 blog
items.
Read updated news, blogs, and resources about Abbott Laboratories. Find user-submitted articles and reactions on Abbott Laboratories from
like-minded professionals.
News
Please add new articles to this topic
In a lawsuit filed in New York Supreme Court, Wolf Haldenstein claimed that Grant Eisenhofer had failed to pay its fair...
The Nebraska Attorney General's Office Medicaid Fraud Unit recovered more than $20 million from fraudulent Medicaid...
Abbott Park, Illinois and North Chicago - Abbott will announce its fourth-quarter and full-year 2012 financial results...
Deutsche Bank lowered shares of Abbott Laboratories (NYSE: ABT) from a buy rating to a hold rating in a research report...
Abbott Laboratories engages in the development, manufacture, and sale of health care products worldwide with a 40-year...
Oasmia Pharmaceutical AB rose the most on record after it signed a license and distribution agreement with Abbott...
Abbott Vascular’s next-generation device, which dissolves in the bloodstream, is moving to the clinical test phase in...
ABBOTT PARK, Ill., Jan. 8, 2013 /PRNewswire/ -- Abbott announced today the initiation of the ABSORB III clinical trial...
According to one Street.com writer, Abbott's portfolio of businesses are aligned with favorable long-term healthcare...
Abbott Laboratories (NYSE:ABT) has just announced that it has completed the separation of its research-based...
The stock moved sideways a bit and then moved down another two weeks before it found the support level it liked.
Investors gave an initial vote of confidence to the decision to split Abbott Laboratories into two businesses, lifting...
Abbott Laboratories (NYSE: ABT) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with...
Analysts see promise and problems for the new companies emerging from North Chicago-based Abbott Laboratories this week.
BUFFALO GROVE — Chetan Thakkar and Sangita Chetan Thakkar purchased a home Oct. 4 at 306 Vintage Lane in Buffalo Grove...
Regulators approved Pfizer’s Xeljanz treatment, which is now poised to compete with Abbott Laboratories’ top-selling...
North Chicago-based Abbott Laboratories is laying off 550 workers globally, including 100 in the Chicago metropolitan...
Dec 5 - Fitch Ratings has affirmed Abbott Laboratories' (ABT/Abbott)long-term ratings at 'A+', and removed the Negative...
Abbott Laboratories' spun-off drug business, AbbVie, is being valued at just more than $55 billion -- a few billion...
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Cisco...
NEW YORK: Abbott Laboratories Inc has instructed its sales representatives in India not to give gifts to doctors, who...
NASDAQ News: Abbott Labs Net Surges on Higher Margins
Top Sources: Abbott Laboratories
- BusinessWeek
- MarketWatch
- Reuters
- Chicago Tribune
- thedeal.com
- chicagobusiness.com
- CNN Money
- TheStreet.com
- CNBC
- innovationexcellence.com
